IBERE PHARMACEUTICALS's ticker is IBER and the CUSIP is G46843101. A total of 49 filers reported holding IBERE PHARMACEUTICALS in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $6,666 | -99.9% | 660,664 | +1.2% | 0.00% | 0.0% |
| Q3 2022 | $6,468,000 | +42.1% | 652,664 | +40.7% | 0.00% | +33.3% |
| Q2 2022 | $4,552,000 | +4.5% | 463,967 | -16.6% | 0.00% | +50.0% |
| Q1 2022 | $4,358,000 | -1.9% | 556,377 | -15.3% | 0.00% | 0.0% |
| Q4 2021 | $4,441,000 | +32.8% | 657,147 | +35.4% | 0.00% | 0.0% |
| Q3 2021 | $3,345,000 | +44.4% | 485,490 | +47.3% | 0.00% | +100.0% |
| Q2 2021 | $2,317,000 | – | 329,490 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |